Skip to content

    Bioventus (BVS) stock price & financials

    View BVS earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+84.8% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $138.96M
    $153.64M
    $123.88M
    $147.66M
    $138.65M
    -0.2%
    $157.90M
    +2.8%
    $132.09M
    +6.6%
    $153.21M
    +3.8%
    Strengthening
    Operating Profit
    $3.65M
    $7.70M
    $4.87M
    $18.37M
    $11.25M
    +208.5%
    $19.49M
    +153.0%
    $8.42M
    +72.8%
    $19.13M
    +4.1%
    Strengthening
    Net Profit
    -$5.17M
    -$388.0K
    -$2.64M
    $7.46M
    $3.15M
    $14.76M
    $3.11M
    $33.44M
    +348.3%
    Strengthening
    EPS
    $-0.08
    $-0.04
    $0.11
    $0.05
    $0.05
    $0.49
    +345.5%
    Strengthening
    Other Income
    -$8.91M
    -$7.76M
    -$8.29M
    -$8.05M
    -$6.58M
    +26.1%
    -$5.34M
    +31.1%
    -$3.90M
    +52.9%
    -$3.82M
    +52.6%
    Strengthening
    Interest
    Depreciation
    Profit before Tax
    -$5.26M
    -$53.0K
    -$3.42M
    $10.31M
    $4.67M
    $14.14M
    $4.52M
    $15.31M
    +48.4%
    Strengthening
    MarginsOPM
    2.6%
    5.0%
    3.9%
    12.4%
    8.1%
    +209.9%
    12.3%
    +146.3%
    6.4%
    +62.1%
    12.5%
    +0.3%
    Strengthening
    Tax
    -11.2%
    -1037.7%
    2.8%
    10.1%
    14.2%
    -22.4%
    +97.8%
    12.6%
    +354.7%
    -136.5%
    -1452.9%
    Weakening
    ReturnsROIC
    1.7%
    0.1%
    0.9%
    -2.5%
    -1.1%
    -161.1%
    -4.9%
    -3902.8%
    -1.0%
    -218.1%
    -11.2%
    -348.3%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$86.84M$43.93M$30.19M$36.96M$41.58M$51.24M$29.46M
    Short-Term Investments
    Total Current Assets$211.79M$263.10M$272.57M$268.00M$275.61M$272.84M$257.53M
    Net PP&E$21.84M$40.17M$44.34M$49.96M$33.52M$27.02M$24.75M
    Goodwill$49.80M$147.62M$7.46M$7.46M$7.46M$7.46M$7.46M
    Intangibles$191.65M$695.19M$639.85M$482.35M$404.73M$368.42M$351.05M
    Total Assets$494.47M$1.23B$1.37B$810.91M$727.96M$683.56M$673.35M
    LiabilitiesTotal Current Liabilities$122.59M$180.86M$304.02M$175.50M$210.40M$160.38M$152.45M
    Short-Term Debt$15.00M$18.04M$33.06M$27.85M$27.34M$15.00M$18.75M
    Long-Term Debt$173.38M$339.64M$385.01M$367.00M$308.29M$278.95M$229.70M
    Long-Term Leases$14.11M$15.04M$14.36M$10.57M$6.94M$4.46M$2.92M
    Total Liabilities$350.31M$618.21M$960.43M$589.79M$542.35M$455.11M$395.93M
    EquityCommon Stock & APIC
    Retained Earnings-$6.60M-$165.31M-$321.54M-$357.66M-$334.93M-$298.38M
    Total Equity$458.92M$325.24M$173.59M$147.94M$184.10M$228.31M
    HighlightsNet Cash / (Debt)-$101.54M-$313.75M-$387.88M-$357.88M-$294.05M-$242.71M-$219.00M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$40.71M$71.80M$22.99M-$13.54M$15.34M$38.80M$74.67M$96.87M
    Cash from Investing-$7.91M-$20.50M-$283.76M-$116.44M$15.81M$22.96M-$3.25M-$4.09M
    Cash from Financing-$10.95M-$29.57M$273.37M$62.08M-$26.65M-$54.58M-$62.14M-$95.00M
    SummaryCapital Expenditure-$2.34M-$16.58M-$13.52M-$1.48M-$7.36M-$1.01M-$2.56M-$2.59M
    Free Cash Flow$38.37M$55.22M$9.47M-$15.02M$7.98M$37.79M$72.11M$94.29M
    FCF Margin11.3%17.2%2.2%-2.9%1.6%6.6%12.7%16.2%

    Ratios